Australia court supports human gene patent

2013-02-15 09:29
DNA. (Picture: Supplied)

DNA. (Picture: Supplied)

Multimedia   ·   User Galleries   ·   News in Pictures Send us your pictures  ·  Send us your stories

Canberra - An Australian court ruled on Friday that two technology companies could hold a patent on genetic material related to cancer, in a case similar to one before the US Supreme Court that has implications for gene-based medicine worldwide.

Cancer support groups said the finding could stifle new breast cancer research and treatment. Australia's Federal Court ruled that US company Myriad Genetics and Melbourne-based Genetic Technologies had the right to hold a patent on human genetic material.

The material is known as BRCA1, a mutation associated with higher risk of hereditary breast and ovarian cancer.

The US Supreme Court will consider the same issue, which could affect millions of people worldwide, later this year.

In Australia, trial judge John Nicholas found the material could be subject to a patent because it could not exist naturally on its own inside or outside the human body.


He found those who develop a way of isolating it should have the right to a patent and to reap the financial rewards.

"It would lead to very odd results if a person whose skill and effort culminated in the isolation of a micro-organism... could not be independently rewarded by the grant of a patent," Nicholas said.

The finding disappointed cancer support groups, consumer organisation Cancer Voices, and Brisbane woman Yvonne D'Arcy, who challenged the patents in the Federal Court.

Lawyer Rebecca Gilsenan, who represented D'Arcy and Cancer Voices, said the decision could limit new research because researchers would need the companies' permission to study BRCA1.

"In its isolated form, it is private property of the companies. If researchers want to access it now, they need to get permission or pay for it," Gilsenan said.

"One of the reasons that we agreed to bring this case was because of a concern about access to research, development of treatments and cures for genetically transmitted diseases."

Gilsenan said she was likely to appeal against the finding in a higher court.

Australian Cancer Council chief executive Ian Olver said the finding would allow private companies to monopolise tests for the genetic mutations linked to the risk of breast and ovarian cancer. He said the law must be changed to protect the community "from gene monopolies".

The Australian findings are unlikely to influence the US case. The US Supreme Court is due to hear oral arguments on 15 April, with a decision expected by the end of June.

Justice Nicholas said evidence presented in Australia was different to evidence in the US case, and there were also different constitutional settings for patent laws.

Join the conversation! encourages commentary submitted via MyNews24. Contributions of 200 words or more will be considered for publication.

We reserve editorial discretion to decide what will be published.
Read our comments policy for guidelines on contributions.
Read more on:    technology  |  genetics
NEXT ON NEWS24X publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
Comments have been closed for this article.

Inside News24


Rugby World Cup 2015

All the action from the 2015 RWC, including live coverage of all 48 matches, breaking news, fixtures, results, logs - and much more!


Rugby World Cup 2015

Boks more focused after Japan shock
Pumas, Namibia make 11 changes each
LIVE: New Zealand v Tonga
Springboks' bus driver inspires team in UK
Traffic Alerts

It is always easier to notice the faults in others rather than face our own. Focusing too much on the perfect and ideal more

There are new stories on the homepage. Click here to see them.


Create Profile

Creating your profile will enable you to submit photos and stories to get published on News24.

Please provide a username for your profile page:

This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire network.


Location Settings

News24 allows you to edit the display of certain components based on a location. If you wish to personalise the page based on your preferences, please select a location for each component and click "Submit" in order for the changes to take affect.

Facebook Sign-In

Hi News addict,

Join the News24 Community to be involved in breaking the news.

Log in with Facebook to comment and personalise news, weather and listings.